This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After 177Lu-Peptide Receptor Radionuclide Therapy
- Dosimetry in Radiopharmaceutical Therapy
- Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival
- Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
- Penetrating the Barriers to Successful {alpha}-Radioimmunotherapy
- Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma
- MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy
- Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma
- Cell-Level Dosimetry and Biologic Response Modeling of Heterogeneously Distributed Radionuclides: A Step Forward
- Dosimetry and thyroid cancer: the individual dosage of radioiodine
- 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
- MIRD Commentary: Proposed Name for a Dosimetry Unit Applicable to Deterministic Biological Effects--The Barendsen (Bd)
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry--Standardization of Nomenclature
- Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging-Based Internal Dosimetry
- Lung Dosimetry for Radioiodine Treatment Planning in the Case of Diffuse Lung Metastases
- Electron- and Positron-Emitting Radiolanthanides for Therapy: Aspects of Dosimetry and Production
- Liposome-Mediated Radiotherapeutics Within Avascular Tumor Spheroids: Comparative Dosimetry Study for Various Radionuclides, Liposome Systems, and a Targeting Antibody
- Current Status of Therapy of Solid Tumors
- Dosimetry of Internal Emitters
- Patient-Specific Dosimetry for 131I Thyroid Cancer Therapy Using 124I PET and 3-Dimensional-Internal Dosimetry (3D-ID) Software
- Phase I Clinical Trial with Fractionated Radioimmunotherapy Using 131I-Labeled Chimeric G250 in Metastatic Renal Cancer
- When May a Nonuniform Distribution of 131I Be Considered Uniform? An Experimental Basis for Multicellular Dosimetry
- Irradiation Reduces Interstitial Fluid Transport and Increases the Collagen Content in Tumors
- Optimizing the Sequence of Combination Therapy with Radiolabeled Antibodies and Fractionated External Beam